Invention Grant
- Patent Title: Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitors
-
Application No.: US17082102Application Date: 2020-10-28
-
Publication No.: US11559538B2Publication Date: 2023-01-24
- Inventor: Joseph Walter Strohbach , Tsutomu Akama , David Clive Blakemore , Robert Toms Jacobs , Peter Jones , David Christopher Limburg , Martins Sunday Oderinde , Matthew Alexander Perry , Jacob John Plattner , Rubben Federico Torella , Yasheen Zhou , Thean Yeow Yeoh
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Young-In Julia Oh
- Main IPC: C07F5/02
- IPC: C07F5/02 ; A61K31/69 ; A61K31/519
Abstract:
The present invention relates to boron containing compounds of Formula (IA): that inhibit phosphodiesterase 4 (PDE4). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating diseases, conditions, or disorders ameliorated by inhibition of PDE4.
Public/Granted literature
- US20210069219A1 Boron Containing PDE4 Inhibitors Public/Granted day:2021-03-11
Information query
